European Companies Search Engine

EU funding (€10.5M): H2O Health Outcomes Observatory Hor 1 Oct 2020 EU Research and Innovation programme "Horizon"

Overview

Text

H2O Health Outcomes Observatory

Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain from Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain from Patient-Reported Outcomes (PROs) to accurately measure value from the patient perspective. This is due to the lack of standardisation, interoperability and implementation of PRO measurement schemes. We urgently need a European scale network of outcomes data collection, analysis and evidence sharing to inform clinical practice and healthcare decisions. To tackle these issues, this public-private consortium brings together scientists, clinicians and professionals to design and set up independent, patient-centred, Health Outcomes Observatories (H2Os). With input from patients, providers and health care decision makers (health ministries, health insurers, regional health authorities, public health agencies, medicines regulators, health technology assessment agencies), these Observatories will collect data and provide information not only for individual clinical care, but also for evaluation of new technologies and for healthcare decision making. We will establish ethically and legally sound national, or regional, H2Os and run these initially in four countries for three diseases. Based on a hybrid model of federated and centralised data collection, management and analysis, these Observatories will operate under a governance model that will guarantee that data are protected under jurisdictional data protection law. H2Os will be connected to a pan-European umbrella H2O to facilitate interoperability, guide reproducibility in other countries, and promote the benefit of measuring and using patient-centred outcomes at regional, national, European and global levels.


Funded Companies:

Company name Funding amount
Abbvie Inc. €0.00
Astrazeneca AB €0.00
Breakthrough T1D €0.00
Charite - Universitaetsmedizin Berlin €1,126,008
Eli Lilly and Company Ltd. €0.00
Erasmus Universitair Medisch Centrum Rotterdam €1,279,661
F. Hoffmann-LA Roche AG €0.00
Forum des Patients Europeens €450,413
Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca €0.00
Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) €0.00
H2O PAN European Observatory €54,688
Health Outcomes Observatory - Germany (H2O) e. V. €65,188
Health Outcomes Observatory Nederland (H2O-NL) €4,687.50
Institut Catala de La Salut €1,068,039
Katholieke Universiteit Leuven €458,188
King's College London €655,000
Medizinische Universitaet Wien €2,102,974
Medtronic International Trading Sàrl €0.00
Novartis Pharma AG €0.00
Pfizer Ltd. €0.00
Region Stockholm €548,375
Sanofi-Aventis Recherche & Developpement €0.00
Stichting Integraal Kankercentrum Nederland €563,813
Takeda Pharmaceuticals International AG €0.00
Teamit Research SL €665,719
THE European Institute for Innovation Through Health Data €564,625
THE Hyve B.V. €536,250
Trial Nation €0.00
Universita Vita-Salute SAN Raffaele €333,063

Source: https://cordis.europa.eu/project/id/945345

The filing refers to a past date, and does not necessarily reflect the current state.